1. Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin- releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 
Francesca Sagnella, M.D., Rosanna Apa, M.D., Maurizio Guido, M.D., Paola Villa, M.D., Valentina Spadoni, M.D., Fiorella Miceli, M.D., Antonio Lanzone, M.D. 
Fertility and Sterility 
Volume 91, Issue 5, Pages (May 2009)
DOI: /j.fertnstert
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
(a) FSH plasma levels in PCOS and in control group at each time studied; values are expressed as mean ± SD. (b) LH plasma levels in PCOS and in control group at each time studied; values are expressed as mean ± SD. (c) T plasma levels in PCOS and in control group; values are expressed as percentage in respect to the baseline to which a value of 100 is assigned. Statistical differences are calculated between PCOS and control groups at each studied point. Statistical analysis was performed using ANOVA followed by the Wilcoxon-Mann-Whitney test for comparison of data derived from two groups (each one made up of 10 women). Values with P<.05 were considered statistically significant. CTR = control.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Follicle-stimulating hormone, LH, A, T, 17-OH-P, and E2 sAUC during treatment in PCOS and control groups. Values are calculated as indicated in Materials and Methods section. Statistical analysis was performed with use of ANOVA followed by the Wilcoxon–Mann-Whitney test for comparison of data derived from two groups (each one made up of 10 women). Values with P<.05 were considered statistically significant. CTR = control.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions